Preclinical Lutetium-177 Intracellular Dosimetry of Target Cancers in Radionuclide Therapy. [PDF]
Lunev AS +4 more
europepmc +1 more source
Dosimetry-guided peptide receptor radionuclide therapy in neuroendocrine tumors: interim safety analysis of the DUONEN trial. [PDF]
Kolodziej M +29 more
europepmc +1 more source
Peptide Receptor Radionuclide Therapy or Everolimus in Metastatic Neuroendocrine Tumors: The SeqEveRIV Study, a National Study from the French Group of Endocrine Tumors and Endocan–RENATEN Network [PDF]
Aurelien Fosse +15 more
openalex +1 more source
177 Lu-DOTATATE Radionuclide Therapy: Current Status and Trends
GE Roytberg +4 more
openalex +1 more source
Effects of Targeted Radionuclide Therapy on Cancer Cells Beyond the Ablative Radiation Dose. [PDF]
Ferro-Flores G +5 more
europepmc +1 more source
Prevention and Management of Peptide Receptor Radionuclide Therapy-Induced Hypertensive Crisis in a Patient With Metastatic Pheochromocytoma [PDF]
Run Yu +3 more
openalex +1 more source
68Ga-DOTA-NOC PET and Peptide Receptor Radionuclide Therapy in Management of Bilateral Ovarian Metastases from Gastrointestinal Carcinoid [PDF]
Sahil Singla +4 more
openalex +1 more source

